心房細動における全身栓塞事件:NOACとワルファリンにランダム化された71,683人の参加者の個々の患者データメタ分析

Samer Al Said¹, Eugene Braunwald¹, Michael G Palazzolo¹

¹Thrombolysis in Myocardial Infarction Study Group, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA (S.A.S., E.B., M.G.P., G.E.M.M., C.T.R., E.M.A., R.P.G.).

Circulation

|January 30, 2026

まとめ

システミックエンボリックイベント (SEE) は,心房細動の深刻な合併症です. 非ビタミンKアンタゴニストの経口抗凝固剤は,SEEが不全性脳卒中よりも頻度が低いにもかかわらず,ウォルファリンと比較してSEEのリスクを大幅に低下させた.

科学分野:

心臓病学心臓病学
薬理学薬理学とは
クリニック・リサーチ臨床研究

背景:

システミックエンボリックイベント (SEE) は,心房細動 (AF) 患者における重要で認識されていない合併症です.
非ビタミンKアンタゴニスト経口抗凝固剤 (NOACs) は,不全性脳卒中 (IS) に対して有効ですが,SEEおよび患者の特徴に対するその影響は十分に理解されていません.

研究の目的:

AF患者におけるSEEの発生率,臨床的特徴,管理,およびアウトカムを特徴づけること.
SEEの予防におけるNOACsとワルファリンの有効性を比較する.
AF患者のSEEの予測要因を特定する.

主な方法:

AF患者のNOACとワルファリンを比較した4つのピボタルランダム化試験 (2005年−2010年) の個々の患者データを分析した.
臨床的に明らかなSEEが特定され,特徴づけられ,ISと比較した結果が出た.
SEEの予測要因は,多変量分析によって特定されました.

主要な成果:

71,683人の患者の間で,年率のSEE率は0.13%であったが,ISでは1.25%であった.
SEEを患った患者は,ISと比較して,年上であり,女性である可能性が高く,外周動脈疾患,以前の心筋梗塞,悪化した腎機能,および非心筋梗塞性AFの割合が高かった.
NOACは,ワーファリンと比較してSEEのリスクを29%減少させた (HR,0.71;P=0.04). SEEは,長期的な死亡リスクのほぼ3倍の増加と関連していました.

結論:

NOACsは,AF患者のワーファリンと比較して,SEEのリスクを大幅に軽減します.
ISより頻度が低いものの,SEEは,短期的な死亡率と同等であり,長期的な罹病率と死亡率もかなり高い.
周周動脈疾患,喫煙,非閉塞性AF,女性,以前のMI,VKA暴露,および腎機能不全はSEEの独立した予測因子です.

キーワード:

さらに関連する動画

28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.1K

08:10

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation

Published on: July 20, 2022

2.2K

関連する概念動画

03:03

Amyloid Fibrils

11.9K

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Amyloid Fibrils

Pulmonary Embolism I: Introduction

696

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

696

01:12

Analysis of Population Pharmacokinetic Data

747

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...

747

01:11

Fibril-associated Collagen

3.4K

Fibril-associated collagens are a type of collagens present in the extracellular matrix with interrupted triple helices or FACIT (Fibril-associated collagens interrupted triple-helices). FACIT help connect and attach the collagen fibrils with each other as well as with other proteins of the extracellular matrix.
For example, the type II collagen fibrils in cartilage have covalently bound type IX fibril-associated collagens at regular intervals. Other types of fibril-associated collagens are...

3.4K

01:24

Data Reporting and Recording

5.4K

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...